Low Molecular Weight Heparin as Thromboprophylaxis in Familial Thrombophilia during the Whole Period of Pregnancy

• References

• 1 Melissari E, Parker CJ, Wilson NV, Monte G, Kanthou C, Pemberton KD, Nicolaides KH, Barrett JJ, Kakkar VV. Use of low molecular weight heparin in pregnancy. Thromb Haemost 1992; 68: 652-656
• 2 Forestier F, Solé Y, Aiach M, Alhanc Gélas M, Daffos F. Absence of transplacental passage of Fragmin (Kabi) during the second and the third trimesters of pregnancy. Thromb Haemost 1992; 67: 180-181
• 3 Harenberg J, Schneider D, Heilmann L, Wolf H. Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women. Haemostasis 1993; 23: 314-320
• 4 Wahlberg TB, Kher A. Low molecular weight heparin as thromboprophylaxis in pregnancy. Haemostasis 1994; 24: 55-56
• 5 Kelbel C, Hafner G, Schinzel H, Prellwitz W, Weilemann LS. Einsatz von niedermolekularem Heparin zur Anticoagulation in der Schwangerschaft. Dtsch med Wschr 1994; 119: 1497-1500
• 6 Barrowcliffe TW. Low molecular weight heparin(s). Br J Haematol 1995; 90: 1-6
• 7 Ginsberg JS, Hirsh J. Anticoagulants during pregnancy. Ann Rev Med 1989; 40: 79-86